138 related articles for article (PubMed ID: 2610051)
1. The renal kallikrein-kinin system in renoparenchymal hypertension.
Ando T; Shimamoto K; Ura N; Yokoyama T; Fukuyama S; Yamaguchi Y; Nakagawa H; Mori Y; Ogata H; Iimura O
Adv Exp Med Biol; 1989; 247B():127-32. PubMed ID: 2610051
[TBL] [Abstract][Full Text] [Related]
2. The role of renal kallikrein-kinin system and prostaglandins in diuresis and natriuresis following saline infusion in normotensives and essential hypertensives.
Nishimiya T; Shimamoto K; Tanaka S; Ura N; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Masuca A; Iimura O
Adv Exp Med Biol; 1986; 198 Pt B():337-42. PubMed ID: 3643730
[TBL] [Abstract][Full Text] [Related]
3. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive studies on the renal kallikrein-kinin system in essential hypertension.
Nakahashi Y; Shimamoto K; Ura N; Tanaka S; Nishitani T; Ishida H; Yokoyama T; Ando T; Iimura O
Adv Exp Med Biol; 1986; 198 Pt B():351-7. PubMed ID: 3028078
[TBL] [Abstract][Full Text] [Related]
5. Role of renal kallikrein in the increased fractional sodium excretion in the rat remnant kidney model of chronic renal failure.
Kanazawa M; Abe K; Yasujima M; Yoshida K; Kohzuki M; Tanno M; Kasai Y; Omata K; Sato M; Takeuchi K
Adv Exp Med Biol; 1989; 247B():449-54. PubMed ID: 2610088
[TBL] [Abstract][Full Text] [Related]
6. Physiological role of renal kallikrein-kinin system in human.
Shimamoto K; Iimura O
Adv Exp Med Biol; 1989; 247A():87-96. PubMed ID: 2557757
[TBL] [Abstract][Full Text] [Related]
7. The renal kallikrein-kinin system in human and in experimental hypertension.
Carretero OA; Scicli AG
Klin Wochenschr; 1978; 56 Suppl 1():113-25. PubMed ID: 366276
[TBL] [Abstract][Full Text] [Related]
8. Study on the renal kallikrein-kinin system in normal and low renin subgroups of essential hypertension.
Iimura O; Shimamoto K; Ura N; Mita T; Tanaka S; Nishimiya T; Nakagawa M; Yamaguchi Y
J Hypertens Suppl; 1984 Dec; 2(3):S297-9. PubMed ID: 6100742
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretions of kininase I and kininase II activities in essential hypertension. A sensitive and simple method for its kinin-destroying capacity.
Ura N; Shimamoto K; Tanaka S; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O
J Clin Hypertens; 1985 Mar; 1(1):15-22. PubMed ID: 3014073
[TBL] [Abstract][Full Text] [Related]
10. Effect of pH and amiloride on the intrarenal formation of kinins.
Scicli AG; Diaz MA; Carretero OA
Am J Physiol; 1983 Aug; 245(2):F198-203. PubMed ID: 6554047
[TBL] [Abstract][Full Text] [Related]
11. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
Shimamoto K; Ura N; Nishimura M; Iimura O
Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
[TBL] [Abstract][Full Text] [Related]
12. Urinary kallikrein activity in the hypertension of renal parenchymal disease.
Mitas JA; Levy SB; Holle R; Frigon RP; Stone RA
N Engl J Med; 1978 Jul; 299(4):162-5. PubMed ID: 661889
[TBL] [Abstract][Full Text] [Related]
13. Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.
Shimamoto K; Tanaka S; Nakao T; Ando T; Nakahashi Y; Sakuma M; Miyahara M
Jpn Circ J; 1979 Mar; 43(3):147-52. PubMed ID: 109645
[TBL] [Abstract][Full Text] [Related]
14. [Kidney kallikrein-kinin system in different mechanisms of diuresis].
Zharova EA; Sokolova RI; Nekrasova AA
Biull Eksp Biol Med; 1977 Aug; 84(8):141-3. PubMed ID: 907812
[TBL] [Abstract][Full Text] [Related]
15. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
Nasjletti A; Colina-Chourio J; McGiff JC
Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
[TBL] [Abstract][Full Text] [Related]
16. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.
Nasjletti A; Colina-Chourio J
Fed Proc; 1976 Feb; 35(2):189-93. PubMed ID: 765163
[TBL] [Abstract][Full Text] [Related]
17. Exaggerated fractional sodium excretion in hypertension with advanced renal disease: the role of renal prostaglandin and kallikrein.
Abe K; Imai Y; Sato M; Haruyama T; Sato K; Hiwatari M; Kasai Y; Itoh S; Yasujima M; Seino M; Yoshinaga K
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():327s-330s. PubMed ID: 6914940
[TBL] [Abstract][Full Text] [Related]
18. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
Kunii N
Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion.
Saitoh S; Scicli AG; Peterson E; Carretero OA
Hypertension; 1995 May; 25(5):1008-13. PubMed ID: 7737707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
